{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:11:00Z","timestamp":1788433860560,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1124\/dmd.113.051870","type":"journal-article","created":{"date-parts":[[2013,5,25]],"date-time":"2013-05-25T03:54:19Z","timestamp":1369454059000},"page":"1548-1556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs"],"prefix":"10.1016","volume":"41","author":[{"given":"Youssef","family":"Daali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.051870_bib1","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1093\/clinids\/5.Supplement_3.S428","article-title":"Pharmacokinetics and metabolism of rifampin in humans","volume":"5","author":"Acocella","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1124\/dmd.113.051870_bib2","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/mp900253n","article-title":"The drug transporter-metabolism alliance: uncovering and defining the interplay","volume":"6","author":"Benet","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.113.051870_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-2275(20)38547-3","article-title":"Role of the hepatocyte microtubular system in the excretion of bile salts and biliary lipid: implications for intracellular vesicular transport","volume":"29","author":"Crawford","year":"1988","journal-title":"J Lipid Res"},{"key":"10.1124\/dmd.113.051870_bib4","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1097\/00004728-199911001-00022","article-title":"Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals","volume":"23","author":"de Ha\u00ebn","year":"1999","journal-title":"J Comput Assist Tomogr"},{"key":"10.1124\/dmd.113.051870_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/03602530903491683","article-title":"Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects","volume":"42","author":"Fahrmayr","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.113.051870_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/jhep.2000.8539","article-title":"Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2","volume":"32","author":"Fattinger","year":"2000","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.051870_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.113.051870_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.113.051870_bib9","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.113.051870_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/00004424-200212000-00007","article-title":"Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid interaction with clinical drugs in rats","volume":"37","author":"Kato","year":"2002","journal-title":"Invest Radiol"},{"key":"10.1124\/dmd.113.051870_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-642-14541-4_8","article-title":"Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy","volume":"201","author":"Keppler","year":"2011","journal-title":"Handbook Exp Pharmacol"},{"key":"10.1124\/dmd.113.051870_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/17425250902911463","article-title":"In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions","volume":"5","author":"Kindla","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.113.051870_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/clpt.2012.79","article-title":"A perspective on efflux transport proteins in the liver","volume":"92","author":"K\u00f6ck","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.051870_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2133\/dmpk.24.37","article-title":"In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney","volume":"24","author":"Kusuhara","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.113.051870_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.clpt.6100038","article-title":"Effects of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers","volume":"81","author":"Lau","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.051870_bib16","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.3748\/wjg.14.7059","article-title":"Aquaporins: their role in cholestatic liver disease","volume":"14","author":"Lehmann","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1124\/dmd.113.051870_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0026-895X(24)12069-X","article-title":"Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione","volume":"58","author":"Li","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.051870_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.113.051870_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/jpet.110.175406","article-title":"How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver","volume":"336","author":"Millet","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.051870_bib20","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.105.008748","article-title":"Inhibition of bile acid transport across Na+\/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs","volume":"34","author":"Mita","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051870_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jhep.2005.08.021","article-title":"Canalicular membrane localization of hepatocyte aquaporin-8 is preserved in estradiol-17beta-D-glucuronide-induced cholestasis","volume":"44","author":"Mottino","year":"2006","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.113.051870_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2133\/dmpk.DMPK-11-RV-099","article-title":"Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs","volume":"27","author":"Nakanishi","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.113.051870_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/radiol.12112061","article-title":"Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging","volume":"264","author":"Nassif","year":"2012","journal-title":"Radiology"},{"key":"10.1124\/dmd.113.051870_bib24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2967\/jnumed.112.108233","article-title":"In vivo visualization and quantification of (disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice","volume":"54","author":"Neyt","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1124\/dmd.113.051870_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","article-title":"Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"63","author":"Niemi","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.113.051870_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2133\/dmpk.25.190","article-title":"Hepatitis C virus-related cirrhosis is a major determinant of the expression levels of hepatic drug transporters","volume":"25","author":"Ogasawara","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.113.051870_bib27","article-title":"Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans","author":"Oh","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.113.051870_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.2291020726","article-title":"Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation","volume":"229","author":"Pastor","year":"2003","journal-title":"Radiology"},{"key":"10.1124\/dmd.113.051870_bib29","doi-asserted-by":"crossref","first-page":"24534","DOI":"10.1074\/jbc.271.40.24534","article-title":"Competition for tetrahydrobiopterin between phenylalanine hydroxylase and nitric oxide synthase in rat liver","volume":"271","author":"Pastor","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.051870_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cmmi.1511","article-title":"Concentrations of Gd-BOPTA in cholestatic fatty rat livers: role of transport functions through membrane proteins","volume":"8","author":"Pastor","year":"2013","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1124\/dmd.113.051870_bib31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.apradiso.2004.11.002","article-title":"Direct evidence of the temperature dependence of Gd-BOPTA transport in the intact rat liver","volume":"62","author":"Planchamp","year":"2005","journal-title":"Appl Radiat Isot"},{"key":"10.1124\/dmd.113.051870_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1124\/mol.106.030759","article-title":"Function of both sinusoidal and canalicular transporters controls the concentration of organic anions within hepatocytes","volume":"71","author":"Planchamp","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.051870_bib33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.rli.0000183053.08921.2b","article-title":"Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA","volume":"40","author":"Planchamp","year":"2005","journal-title":"Invest Radiol"},{"key":"10.1124\/dmd.113.051870_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17425251003713519","article-title":"Efflux and uptake transporters as determinants of statin response","volume":"6","author":"Rodrigues","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.113.051870_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.113.051870_bib36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2133\/dmpk.DMPK-10-RV-094","article-title":"Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions","volume":"26","author":"Shitara","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.113.051870_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2006.03.003","article-title":"Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions","volume":"112","author":"Shitara","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.113.051870_bib38","article-title":"Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy","author":"Simon","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.113.051870_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.113.051870_bib40","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/mp200160t","article-title":"The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [\u00b9\u00b9C]telmisartan","volume":"8","author":"Takashima","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.113.051870_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2967\/jnumed.111.098681","article-title":"PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me","volume":"53","author":"Takashima","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1124\/dmd.113.051870_bib42","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1194\/jlr.M400412-JLR200","article-title":"Membrane microdomains in hepatocytes: potential target areas for proteins involved in canalicular bile secretion","volume":"46","author":"Tietz","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1124\/dmd.113.051870_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.102.043026","article-title":"Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation","volume":"304","author":"Tirona","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.051870_bib44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1124\/dmd.113.051870_bib45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2012.01.031","article-title":"Primovist, Eovist: what to expect?","volume":"57","author":"Van Beers","year":"2012","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.113.051870_bib46","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.113.051870_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2003.10.008","article-title":"The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma","volume":"40","author":"Vavricka","year":"2004","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.113.051870_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2002.34133","article-title":"Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver","volume":"36","author":"Vavricka","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.051870_bib49","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.108.146647","article-title":"Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans","volume":"328","author":"Watanabe","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.051870_bib50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10928-010-9176-y","article-title":"Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans","volume":"37","author":"Watanabe","year":"2010","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.113.051870_bib51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev-pharmtox-011112-140309","article-title":"Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms","volume":"53","author":"Yoshida","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.113.051870_bib52","doi-asserted-by":"crossref","first-page":"23538","DOI":"10.1074\/jbc.M303504200","article-title":"Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2)","volume":"278","author":"Zelcer","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.051870_bib53","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1021\/mp900132e","article-title":"Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions","volume":"6","author":"Zhang","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.113.051870_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/clpt.2008.186","article-title":"Elucidating rifampin\u2019s inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite","volume":"85","author":"Zheng","year":"2009","journal-title":"Clin Pharmacol Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.051870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:10:35Z","timestamp":1739905835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624097861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0090955624097861"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.051870","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.051870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}